CVS Health’s narrative has shifted with a slightly higher fair value estimate, nudging from about $91.50 to roughly $92.40 ...

CVS is a strong buy now, with rising earnings, solid dividends, and steady growth prospects despite industry challenges. Read ...

CVS Health raises its 2025 revenue outlook as Bank of America highlights stronger margins, new tech investments, and momentum ...

CVS Health (CVS) just put fresh numbers on the table, raising its outlook for 2025 and sketching out higher earnings in 2026, ...

The outlook suggests Rhode Island-based CVS expects to manage a volatile environment that has posed challenges for all three ...

CVS to Pay $37.8 Million to Settle Overbilling Claims - CVS Pharmacy, Inc. agreed to pay $37.8 million to settle several lawsuits ...

CVS Health ( ($CVS) ) has provided an update. On December 9, 2025, CVS Health held its 2025 Investor Day, where it updated ...

CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained ...

CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...

CVS Health agreed to pay $37.76 million to settle allegations that it dispensed too many insulin pens to patients and ...

A national pharmacy chain agreed to a $37.76 million settlement after federal investigators found it dispensed excess insulin ...

The pharmacy admits to wrong doing and will fork out more than $24 million to the federal government and the remainder will ...